Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0000899243-22-036184 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-17 | 2022-11-15 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale | $308.61 | -34 | 36.1K | -0.1% | -$10.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-15 | S | D | 34 | $308.61 | 36,077 | D | — | — |